BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32780208)

  • 21. Clinical and ultrasound features of benign, borderline, and malignant invasive mucinous ovarian tumors.
    Pascual A; Guerriero S; Rams N; Juez L; Ajossa S; Graupera B; Hereter L; Cappai A; Pero M; Perniciano M; Errasti T; Parra J; Solis M; Alcázar JL
    Eur J Gynaecol Oncol; 2017; 38(3):382-386. PubMed ID: 29693878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.
    Zacharakis D; Thomakos N; Biliatis I; Rodolakis A; Simou M; Daskalakis G; Bamias A; Antsaklis A
    Acta Obstet Gynecol Scand; 2013 Mar; 92(3):285-92. PubMed ID: 23193945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
    Ronnett BM; Kajdacsy-Balla A; Gilks CB; Merino MJ; Silva E; Werness BA; Young RH
    Hum Pathol; 2004 Aug; 35(8):949-60. PubMed ID: 15297962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors.
    Moon MH; Park HS; Kim YJ; Yu MH; Park S; Jung SI
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
    Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
    Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraovarian/paratubal cysts: comparison of transvaginal sonographic and pathological findings to establish diagnostic criteria.
    Savelli L; Ghi T; De Iaco P; Ceccaroni M; Venturoli S; Cacciatore B
    Ultrasound Obstet Gynecol; 2006 Sep; 28(3):330-4. PubMed ID: 16823765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian masses with papillary projections diagnosed and removed during pregnancy: ultrasound features and histological diagnosis.
    Mascilini F; Savelli L; Scifo MC; Exacoustos C; Timor-Tritsch IE; De Blasis I; Moruzzi MC; Pasciuto T; Scambia G; Valentin L; Testa AC
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):116-123. PubMed ID: 27484484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional ultrasound and HDlive in tubal serous cystadenofibroma: a case report and literature review.
    Grigore M; Popovici R; Furnica C; Pristavu A; Hamod A; Gafitanu D
    Med Ultrason; 2017 Nov; 19(4):444-446. PubMed ID: 29197922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preoperative diagnosis of borderline ovarian tumors: a review of current literature.
    Morotti M; Menada MV; Gillott DJ; Venturini PL; Ferrero S
    Arch Gynecol Obstet; 2012 Apr; 285(4):1103-12. PubMed ID: 22210294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: Correlation with clinicopathological features.
    Ciepliński K; Jóźwik M; Semczuk-Sikora A; Gogacz M; Lewkowicz D; Ignatov A; Semczuk A
    Histol Histopathol; 2018 Feb; 33(2):171-179. PubMed ID: 28493257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of ultrasonography combined with carbohydrate antigen 125 and 19-9 detection in the diagnosis of borderline ovarian tumors and prediction of recurrence.
    Niu L; Wang W; Xu Y; Xu T; Sun J; Lv W; Zhang J; Qiu L; Dong X; Shang Y; Zhang L; Wang J
    Front Surg; 2022; 9():951472. PubMed ID: 36760664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive Cancers.
    Zheng G; Yu H; Kanerva A; Försti A; Sundquist K; Hemminki K
    Cancer Epidemiol Biomarkers Prev; 2018 Nov; 27(11):1358-1363. PubMed ID: 30018148
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.
    Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK
    Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Imaging Tools for the Diagnosis of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis.
    Borrelli GM; de Mattos LA; Andres MP; Gonçalves MO; Kho RM; Abrão MS
    J Minim Invasive Gynecol; 2017; 24(3):353-363. PubMed ID: 28027973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in ultrasound features of papillations in unilocular-solid adnexal cysts: a retrospective international multicenter study.
    Landolfo C; Valentin L; Franchi D; Van Holsbeke C; Fruscio R; Froyman W; Sladkevicius P; Kaijser J; Ameye L; Bourne T; Savelli L; Coosemans A; Testa A; Timmerman D
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):269-278. PubMed ID: 29119698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
    Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?
    Lee EJ; Kim SH; Kim YH; Lee HJ
    Acta Radiol; 2011 May; 52(4):458-62. PubMed ID: 21498310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum.
    Hinson SA; Silva EG; Pinto K
    Ann Diagn Pathol; 2013 Jun; 17(3):302-4. PubMed ID: 22921726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrasound features of different histopathological subtypes of borderline ovarian tumors.
    Fruscella E; Testa AC; Ferrandina G; De Smet F; Van Holsbeke C; Scambia G; Zannoni GF; Ludovisi M; Achten R; Amant F; Vergote I; Timmerman D
    Ultrasound Obstet Gynecol; 2005 Nov; 26(6):644-50. PubMed ID: 16254875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.